Trial Profile

A Randomized, Double-masked, Multicenter Study to Evaluate the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lubricin (Primary) ; Lifitegrast
Indications Dry eyes
Focus Therapeutic Use
Sponsors Novartis Pharmaceuticals

Most Recent Events

15 Jul 2021 Status changed from recruiting to completed.
01 Apr 2021 Planned End Date changed from 18 Apr 2022 to 21 Mar 2022.
01 Apr 2021 Planned primary completion date changed from 10 Jun 2021 to 13 May 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com